Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Isoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] | ||
Ligand | BDBM585803 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | Cbl-b Displacement Assay (Cbl-b Inhibition Assay low) | ||
IC50 | <1±n/a nM | ||
Citation | Sands, AT; Bence, NF; Zapf, CW; Cohen, F; Wang, C; Cummins, T; Tanaka, H; Shunatona, H; Cardozo, M; Weiss, D; Gosling, J Cyano cyclobutyl compounds for CBL-B inhibition and uses thereof US Patent US11530229 Publication Date 12/20/2022 | ||
More Info.: | Get all data from this article, Assay Method | ||
Isoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] | |||
Name: | Isoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] | ||
Synonyms: | CBLB | CBLB_HUMAN | E3 ubiquitin-protein ligase CBL-B [36-427] | RNF56 | ||
Type: | Enzyme Catalytic Domain | ||
Mol. Mass.: | 45487.32 | ||
Organism: | Homo sapiens (Human) | ||
Description: | aa 36-427 (sequence in paper SEQ ID No: 1) | ||
Residue: | 392 | ||
Sequence: |
| ||
BDBM585803 | |||
n/a | |||
Name | BDBM585803 | ||
Synonyms: | US11530229, Compound 18 | ||
Type | Small organic molecule | ||
Emp. Form. | C32H35F3N6O | ||
Mol. Mass. | 576.6551 | ||
SMILES | C[C@H]1C[C@@H](C)CN(Cc2cc3C(=O)N(Cc3c(c2)C(F)(F)F)c2cccc(c2)[C@@]2(Cc3nncn3C)C[C@@H](C2)C#N)C1 |r,wU:37.43,wD:28.30,1.0,3.3,(-10.75,-2.39,;-9.21,-2.39,;-8.44,-3.72,;-6.9,-3.72,;-6.5,-5.21,;-6.13,-2.39,;-6.9,-1.06,;-6.13,.28,;-4.59,.28,;-3.82,1.61,;-2.28,1.61,;-1.25,2.76,;-1.57,4.26,;.16,2.13,;-0,.6,;-1.51,.28,;-2.28,-1.06,;-3.82,-1.06,;-1.51,-2.39,;-2.28,-3.72,;.03,-2.39,;-.74,-3.72,;1.49,2.9,;1.49,4.44,;2.82,5.21,;4.16,4.44,;4.16,2.9,;2.82,2.13,;5.49,2.13,;4.16,1.36,;4.16,-.18,;2.91,-1.09,;3.39,-2.55,;4.93,-2.55,;5.4,-1.09,;6.87,-.61,;6.58,1.04,;7.67,2.13,;6.58,3.22,;9.21,2.13,;10.75,2.13,;-8.44,-1.06,)| | ||
Structure |